Covidien (Dublin, Ireland) witnessed steady growth from its largest business division, medical devices, during the third fiscal quarter, with its oximetry and energy devices units putting in strong performances. Total medical device revenue for the period, was $1.63bn, a 6% improvement ...
Please Login to read the full article.
